Home Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
 

Keywords :   


Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520

2014-06-14 04:22:56| Biotech - Topix.net

Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop ARC-520, its clinical candidate against chronic hepatitis B infection.

Tags: issues statement property protection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
09.05Proactiv Launches New Post Blemish 10% Vitamin C Serum
09.05Celebrity Hairstylist Garren Bestowed with Icon Award at Annual Met Artists Dinner
09.05Interest rates held at 5.25% for sixth time
09.05EPA, FDA and USDA issue joint biotechnology regulatory plan
09.05Apple faces celebrity backlash over piano crushing
09.05Bank of England holds interest rates at 5.25%
09.05Farm Progress America, May 9, 2024
09.05Farm Progress America, May 9, 2024
More »